Carbon monoxide: A vital signalling molecule and potent toxin in the myocardium

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 2, 2012, Pages 359-365

  Peers, Chris ^a   Steele, Derek S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Arrhythmia; Calcium channel; Carbon monoxide; Cardioprotection; Heme oxygenase

Indexed keywords

ANTIOXIDANT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE 3; CARBON MONOXIDE RELEASING MOLECULE A1; CYTOCHROME C OXIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; GUANYLATE CYCLASE; HEME OXYGENASE 1; HEME OXYGENASE 2; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTECTIVE AGENT; PROTEIN KINASE B; PURINERGIC P2X2 RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

CARBON MONOXIDE INTOXICATION; CARDIOTOXICITY; DRUG EFFECT; ENZYME INDUCTION; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARBON MONOXIDE; CARDIOTONIC AGENTS; HEART; HEME OXYGENASE (DECYCLIZING); HUMANS; ION CHANNELS; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84855996537     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.05.013     Document Type: Review

References (95)

1. Haldane J. The relation of the action of carbonic oxide to oxygen tension. J Physiol 1895, 18:201-217. Ref Type: Journal (Full).
2. Sjostrand T. Early studies of CO production. Ann N Y Acad Sci 1970, 174:5-10.
3. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968, 61:748-755.
4. Tenhunen R., Marver H.S., Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 1969, 244:6388-6394.
5. Motterlini R., Otterbein L.E. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov 2010, 9:728-743.
6. 2S and their prodrugs. Burger's medicinal chemistry, drug discovery and development 2010, 1-103. John Wiley & Sons Ltd. 7th Edition. D.J. Abraham, D.P. Rotella (Eds.).
7. Meredith T., Vale A. Carbon monoxide poisoning. Br Med J (Clin Res Ed) 1988, 296:77-79.
8. Cobb N., Etzel R.A. Unintentional carbon monoxide-related deaths in the United States, 1979 through 1988. JAMA 1991, 266:659-663.
9. Varon J., Marik P.E., Fromm R.E., Gueler A. Carbon monoxide poisoning: a review for clinicians. J Emerg Med 1999, 17:87-93.
10. Ewing J.F., Raju V.S., Maines M.D. Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3':5'-guanosine monophosphate. J Pharmacol Exp Ther 1994, 271:408-414.
11. Lakkisto P., Palojoki E., Backlund T., Saraste A., Tikkanen I., Voipio-Pulkki L.M., et al. Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol 2002, 34:1357-1365.
12. Maulik N., Sharma H.S., Das D.K. Induction of the haem oxygenase gene expression during the reperfusion of ischemic rat myocardium. J Mol Cell Cardiol 1996, 28:1261-1270.
13. Grilli A., De Lutiis M.A., Patruno A., Speranza L., Gizzi F., Taccardi A.A., et al. Inducible nitric oxide synthase and heme oxygenase-1 in rat heart: direct effect of chronic exposure to hypoxia. Ann Clin Lab Sci 2003, 33:208-215.
14. McGrath J.J. The effects of carbon monoxide on the heart: an in vitro study. Pharmacol Biochem Behav 1984, 21(Suppl 1):99-102.
15. Yoshida T., Maulik N., Ho Y.S., Alam J., Das D.K. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the Heme oxygenase-1 gene. Circulation 2001, 103:1695-1701.
16. Yet S.F., Perrella M.A., Layne M.D., Hsieh C.M., Maemura K., Kobzik L., et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest 1999, 103:R23-R29.
17. Yet S.F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 2001, 89:168-173.
18. Wang G., Hamid T., Keith R.J., Zhou G., Partridge C.R., Xiang X., et al. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010, 121:1912-1925.
19. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 2008, 60:79-127.
20. Miralem T., Hu Z., Torno M.D., Lelli K.M., Maines M.D. Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells. J Biol Chem 2005, 280:17084-17092.
21. Kim H.P., Pae H.O., Back S.H., Chung S.W., Woo J.M., Son Y., et al. Heme oxygenase-1 comes back to endoplasmic reticulum. Biochem Biophys Res Commun 2011, 404:1-5.
22. West A.R., Oates P.S. Subcellular location of heme oxygenase 1 and 2 and divalent metal transporter 1 in relation to endocytotic markers during heme iron absorption. J Gastroenterol Hepatol 2008, 23:150-158.
23. Williams S.E., Wootton P., Mason H.S., Bould J., Iles D.E., Riccardi D., et al. Hemoxygenase-2 is an oxygen sensor for a calcium-sensitive potassium channel. Science 2004, 306:2093-2097.
24. Imuta N., Hori O., Kitao Y., Tabata Y., Yoshimoto T., Matsuyama T., et al. Hypoxia-mediated induction of heme oxygenase type I and carbon monoxide release from astrocytes protects nearby cerebral neurons from hypoxia-mediated apoptosis. Antioxid Redox Signal 2007, 9:543-552.
25. Motterlini R., Clark J.E., Foresti R., Sarathchandra P., Mann B.E., Green C.J. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002, 90:E17-E24.
26. Clark J.E., Naughton P., Shurey S., Green C.J., Johnson T.R., Mann B.E., et al. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 2003, 93:e2-e8.
27. Guo Y., Stein A.B., Wu W.J., Tan W., Zhu X., Li Q.H., et al. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 2004, 286:H1649-H1653.
28. Musameh M.D., Fuller B.J., Mann B.E., Green C.J., Motterlini R. Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart. Br J Pharmacol 2006, 149:1104-1112.
29. Sylvester J.T., McGowan C. The effects of agents that bind to cytochrome P-450 on hypoxic pulmonary vasoconstriction. Circ Res 1978, 43:429-437.
30. McGrath J.J., Smith D.L. Response of rat coronary circulation to carbon monoxide and nitrogen hypoxia. Proc Soc Exp Biol Med 1984, 177:132-136.
31. McFaul S.J., McGrath J.J. Studies on the mechanism of carbon monoxide-induced vasodilation in the isolated perfused rat heart. Toxicol Appl Pharmacol 1987, 87:464-473.
32. Kharitonov V.G., Sharma V.S., Pilz R.B., Magde D., Koesling D. Basis of guanylate cyclase activation by carbon monoxide. Proc Natl Acad Sci USA 1995, 92:2568-2571.
33. Wu L., Cao K., Lu Y., Wang R. Different mechanisms underlying the stimulation of K(Ca) channels by nitric oxide and carbon monoxide. J Clin Invest 2002, 110:691-700.
34. Wang R., Wu L. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 1997, 272:8222-8226.
35. + channels. Circ Res 2005, 97:805-812.
36. Durante W., Johnson F.K., Johnson R.A. Role of carbon monoxide in cardiovascular function. J Cell Mol Med 2006, 10:672-686.
37. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006, 86:583-650.
38. Durante W. Carbon monoxide and bile pigments: surprising mediators of vascular function. Vasc Med 2002, 7:195-202.
39. Wu L., Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005, 57:585-630.
40. Kim H.P., Ryter S.W., Choi A.M. CO as a cellular signaling molecule. Annu Rev Pharmacol Toxicol 2006, 46:411-449.
41. Boczkowski J., Poderoso J.J., Motterlini R. CO-metal interaction: vital signaling from a lethal gas. Trends Biochem Sci 2006, 31:614-621.
42. Tsiftsoglou A.S., Tsamadou A.I., Papadopoulou L.C. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther 2006, 111:327-345.
43. Brune B., Schmidt K.U., Ullrich V. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 1990, 192:683-688.
44. Piantadosi C.A. Carbon monoxide, reactive oxygen signaling, and oxidative stress. Free Radic Biol Med 2008, 45:562-569.
45. 2+ channels through a nitric oxide-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 2005, 288:G7-G14.
46. Li L., Hsu A., Moore P.K. Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases!. Pharmacol Ther 2009, 123:386-400.
47. Turrens J.F. Mitochondrial formation of reactive oxygen species. J Physiol 2003, 552:335-344.
48. D'Amico G., Lam F., Hagen T., Moncada S. Inhibition of cellular respiration by endogenously produced carbon monoxide. J Cell Sci 2006, 119:2291-2298.
49. Taille C., El-Benna J., Lanone S., Boczkowski J., Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 2005, 280:25350-25360.
50. Hamanaka R.B., Chandel N.S. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci 2010.
51. Piantadosi C.A., Carraway M.S., Babiker A., Suliman H.B. Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ Res 2008, 103:1232-1240.
52. Suliman H.B., Carraway M.S., Tatro L.G., Piantadosi C.A. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 2007, 120:299-308.
53. Suliman H.B., Carraway M.S., Ali A.S., Reynolds C.M., Welty-Wolf K.E., Piantadosi C.A. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J Clin Invest 2007, 117:3730-3741.
54. Lo I.L., Boczkowski J., Zini R., Salouage I., Berdeaux A., Motterlini R., et al. A carbon monoxide-releasing molecule (CORM-3) uncouples mitochondrial respiration and modulates the production of reactive oxygen species. Free Radic Biol Med 2011.
55. Cave A., Grieve D., Johar S., Zhang M., Shah A.M. NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology. Philos Trans R Soc Lond B Biol Sci 2005, 360:2327-2334.
56. Kuroda J., Sadoshima J. NADPH oxidase and cardiac failure. J Cardiovasc Transl Res 2010, 3:314-320.
57. Srisook K., Han S.S., Choi H.S., Li M.H., Ueda H., Kim C., et al. CO from enhanced HO activity or from CORM-2 inhibits both O2- and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem Pharmacol 2006, 71:307-318.
58. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao L.H., Wysk M., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000, 6:422-428.
59. Otterbein L.E., Soares M.P., Yamashita K., Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 2003, 24:449-455.
60. Tongers J., Fiedler B., Konig D., Kempf T., Klein G., Heineke J., et al. Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes. Cardiovasc Res 2004, 63:545-552.
61. Burger D., Xiang F., Hammoud L., Lu X., Feng Q. Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol 2009, 296:H84-H93.
62. Fujimoto H., Ohno M., Ayabe S., Kobayashi H., Ishizaka N., Kimura H., et al. Carbon monoxide protects against cardiac ischemia-reperfusion injury in vivo via MAPK and Akt-eNOS pathways. Arterioscler Thromb Vasc Biol 2004, 24:1848-1853.
63. Voitychuk O.I., Strutynskyi R.B., Yagupolskii L.M., Tinker A., Moibenko O.O., Shuba Y.M. Sarcolemmal cardiac K(ATP) channels as a target for the cardioprotective effects of the fluorine-containing pinacidil analogue, flocalin. Br J Pharmacol 2010.
64. Dallas M.L., Scragg J.L., Peers C. Modulation of hTREK-1 by carbon monoxide. Neuroreport 2008, 19:345-348.
65. v2.1. FASEB J 2011, 25:1519-1530.
66. 2+ signaling in human venous endothelial cells: multiple roles for reactive oxygen species. J Biol Chem 2005, 280:13349-13354.
67. Overholt J.L., Bright G.R., Prabhakar N.R. Carbon monoxide and carotid body chemoreception. Adv Exp Med Biol 1996, 410:341-344.
68. 2+ channel inhibition. Biochem Biophys Res Commun 2005, 334:661-668.
69. 2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species. J Biol Chem 2008, 283:24412-24419.
70. Zima A.V., Blatter L.A. Redox regulation of cardiac calcium channels and transporters. Cardiovasc Res 2006, 71:310-321.
71. Omaye S.T. Metabolic modulation of carbon monoxide toxicity. Toxicology 2002, 180:139-150.
72. Von Burg R. Carbon monoxide. J Appl Toxicol 1999, 19:379-386.
73. Gandini C., Castoldi A.F., Candura S.M., Locatelli C., Butera R., Priori S., et al. Carbon monoxide cardiotoxicity. J Toxicol Clin Toxicol 2001, 39:35-44.
74. Prockop L.D., Chichkova R.I. Carbon monoxide intoxication: an updated review. J Neurol Sci 2007, 262:122-130.
75. Harper A., Croft-Baker J. Carbon monoxide poisoning: undetected by both patients and their doctors. Age Ageing 2004, 33:105-109.
76. Henry C.R., Satran D., Lindgren B., Adkinson C., Nicholson C.I., Henry T.D. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 2006, 295:398-402.
77. Henry T.D., Lesser J.R., Satran D. Myocardial fibrosis from severe carbon monoxide poisoning detected by cardiac magnetic resonance imaging. Circulation 2008, 118:792.
78. Satran D., Henry C.R., Adkinson C., Nicholson C.I., Bracha Y., Henry T.D. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. J Am Coll Cardiol 2005, 45:1513-1516.
79. Adams K.F., Koch G., Chatterjee B., Goldstein G.M., O'Neil J.J., Bromberg P.A., et al. Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease. J Am Coll Cardiol 1988, 12:900-909.
80. Sheps D.S., Herbst M.C., Hinderliter A.L., Adams K.F., Ekelund L.G., O'Neil J.J., et al. Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med 1990, 113:343-351.
81. Carnevali R., Omboni E., Rossati M., Villa A., Checchini M. Electrocardiographic changes in acute carbon monoxide poisoning. Minerva Med 1987, 78:175-178.
82. COSBY R.S., Bergeron M. Electrocardiographic changes in carbon monoxide poisoning. Am J Cardiol 1963, 11:93-96.
83. Macmillan C.S., Wildsmith J.A., Hamilton W.F. Reversible increase in QT dispersion during carbon monoxide poisoning. Acta Anaesthesiol Scand 2001, 45:396-397.
84. Sari I., Zengin S., Ozer O., Davutoglu V., Yildirim C., Aksoy M. Chronic carbon monoxide exposure increases electrocardiographic P-wave and QT dispersion. Inhal Toxicol 2008, 20:879-884.
85. Onvlee-Dekker I.M., De Vries A.C., Ten Harkel A.D. Carbon monoxide poisoning mimicking long-QT induced syncope. Arch Dis Child 2007, 92:244-245.
86. Katzman G.M., Penney D.G. Electrocardiographic responses to carbon monoxide and cyanide in the conscious rat. Toxicol Lett 1993, 69:139-153.
87. Miller K.A., Siscovick D.S., Sheppard L., Shepherd K., Sullivan J.H., Anderson G.L., et al. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med 2007, 356:447-458.
88. Andre L., Boissiere J., Reboul C., Perrier R., Zalvidea S., Meyer G., et al. Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats. Am J Respir Crit Care Med 2010, 181:587-595.
89. Sullivan F.M., Barlow S.M. Review of risk factors for sudden infant death syndrome. Paediatr Perinat Epidemiol 2001, 15:144-200.
90. Schwartz P.J., Stramba-Badiale M., Segantini A., Austoni P., Bosi G., Giorgetti R., et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998, 338:1709-1714.
91. Hoffman J.I., Lister G. The implications of a relationship between prolonged QT interval and the sudden infant death syndrome. Pediatrics 1999, 103:815-817.
92. Guntheroth W.G., Spiers P.S. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998, 339:1161-1163.
93. Sartiani L., Cerbai E., Lonardo G., DePaoli P., Tattoli M., Cagiano R., et al. Prenatal exposure to carbon monoxide affects postnatal cellular electrophysiological maturation of the rat heart: a potential substrate for arrhythmogenesis in infancy. Circulation 2004, 109:419-423.
94. Tattoli M., Carratu M.R., Cassano T., Cortese I., Di G.V., Elia G., et al. Effects of early postnatal exposure to low concentrations of carbon monoxide on cognitive functions in rats. Pharmacol Res 1999, 40:271-274.
95. Szabo C. Gaseotransmitters: new frontiers for translational science. Sci Transl Med 2010, 2:59ps54.